Veru Inc.
NASDAQ:VERU
Overview | Financials
Company Name | Veru Inc. |
Symbol | VERU |
Currency | USD |
Price | 0.734 |
Market Cap | 107,401,941 |
Dividend Yield | 0% |
52-week-range | 0.36 - 1.92 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Mitchell S. Steiner F.A.C.S, F.A.C.S., M.D. |
Website | https://www.verupharma.com |
An error occurred while fetching data.
About Veru Inc.
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD